| Davies, Andrew |
NCT05016609: Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) |
|
|
| Recruiting | 4 | 1800 | RoW | OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid), Sofosbuvir/Velpatasvir (Gilead) | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | Hepatitis C | 04/24 | 06/24 | | |
RITZ, NCT05735834: Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients |
|
|
| Recruiting | 3 | 120 | Europe | Rituximab, Truxima, Zanubrutinib, Brukinsa | International Extranodal Lymphoma Study Group (IELSG) | Splenic Marginal Zone Lymphoma | 05/29 | 05/29 | | |
REMoDL-A, NCT04546620: Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) |
|
|
| Recruiting | 2 | 453 | Europe | R-CHOP, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone, R-CHOP + acalabrutinib, Acalabrutinib | University Hospital Southampton NHS Foundation Trust, AstraZeneca | Diffuse Large B Cell Lymphoma | 01/27 | 07/27 | | |
NCT05233033: Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients With Relapsed or Refractory B-cell NHL |
|
|
| Suspended | 1 | 80 | Europe, US | KT-413 | Kymera Therapeutics, Inc. | Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL, MYD88 Gene Mutation | 04/25 | 05/25 | | |
IELSG37, NCT01599559: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma |
|
|
| Active, not recruiting | N/A | 540 | Europe, Canada, US, RoW | observation, 3D-Conformal Radiotherapy (3D-CRT) | International Extranodal Lymphoma Study Group (IELSG) | Primary Mediastinal B-cell Lymphoma | 06/22 | 12/29 | | |
NCT04932317: Oral Symptom Assessment Scale (OSAS): Validity and Reliability |
|
|
| Completed | N/A | 54 | Europe | | Our Lady's Hospice and Care Services, University of Dublin, Trinity College | Neoplasms | 08/22 | 08/22 | | |
NCT06287294: An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer |
|
|
| Recruiting | N/A | 120 | Europe | | Our Lady's Hospice and Care Services | Taste, Altered, Xerostomia, Neoplasms | 12/25 | 12/25 | | |
| Recruiting | N/A | 200 | Europe | completion of a questionnaire | Prof Andrew Davies | Altered Taste | 12/25 | 12/25 | | |
| Recruiting | N/A | 1320 | Europe | | University of Dublin, Trinity College | Opioid-Induced Constipation | 07/24 | 07/24 | | |
| Recruiting | N/A | 3830 | Europe | Palliative Care and Oncology Survey on Terminology (POST) | Our Lady's Hospice and Care Services, Royal Surrey County Hospital NHS Foundation Trust | Cancer | 10/24 | 10/24 | | |
